MDGL Apr 2025 250.000 put
| Previous close | 42.10 |
| Open | 43.07 |
| Bid | 51.90 |
| Ask | 59.00 |
| Strike | 250.00 |
| Expiry date | 2025-04-17 |
| Day's range | 42.10 - 43.07 |
| Contract range | N/A |
| Volume | |
| Open interest | 52 |
Insider MonkeyIs Madrigal Pharmaceuticals, Inc. (MDGL) the Best Guru Stock To Buy Now?
We recently compiled a list of the 10 Best Guru Stocks To Buy Now. In this article, we will have a look at where Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) ranks among the best guru stocks to buy now. Due to the plethora of investment options such as equities, bonds, and mutual funds that are available today, […]
Simply Wall St.Exploring 3 High Growth Tech Stocks in the United States
Over the last 7 days, the market has dropped 3.4%, but over the longer term, it has risen by 20% in the last year with earnings forecasted to grow by 15% annually. In this dynamic environment, identifying high growth tech stocks that can capitalize on these trends is crucial for investors seeking robust returns.
GlobeNewswireMadrigal Pharmaceuticals, Inc. to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
CONSHOHOCKEN, Pa., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the company will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5, 2024 at 10:45 A.M. ET. The presentation will be webcast live and may be accessed here or by visiting Madrigal’s Investor Relations Events page. A replay of the webcast will be available after the event. About Madrigal PharmaceuticalsMadrigal Pharmaceuticals, Inc
